TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
IDYA

Ideaya Biosciences Inc

Healthcare · Biotechnology

38.40$ -0.5% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Income Statement

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Income Statement IDYA
Line item 2017 2018 2019 2020 2021 2022 2023 2024 2025
100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
203.2% 6.2% 4.1% 17.1% 54.8% 143.9%
100.0% 100.0% 100.0% 82.9% 45.2% -43.9%
203.2% 208.1% 175.8% 553.8% 4,209.6% 143.9%
77.7% 71.8% 46.9% 121.0% 561.5% 29.0%
280.9% 279.9% 222.7% 657.7% 4,716.3% 29.0%
-180.9% -179.9% -122.7% -574.9% -4,671.1% -72.8%
4.3% 1.8% 7.6% 91.8%
-176.6% -178.1% -115.2% -483.0% -3,921.1% -52.0%
-11.4% -8.0% -7.6% 16.4%
-165.1% -170.1% -107.6% -483.0% -3,921.1% -52.0%
-173.8% -173.7% -118.6% -465.9% -3,866.3% -70.7%

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?